Table 1.
Body weight (g) | ||||||
---|---|---|---|---|---|---|
RA for 14 days | CIH for 14 days | |||||
N | At beginning | At termination | N | At beginning | At termination | |
No treatment | 24 | 343.5 ± 11.7 | 390.8 ± 17.6 | 24 | 339.5 ± 13.2 | 372.1 ± 16.8 |
Mn treatment | 10 | 335.7 ± 13.6 | 389.0 ± 19.6 | 20 | 340.6 ± 15.3 | 379.5 ± 17.4 |
Apo treatment | 10 | 338.1 ± 12.8 | 394.0 ± 18.4 | 24 | 330.4 ± 14.1 | 375.4 ± 16.5 |
Veh treatment | 10 | 336.5 ± 14.1 | 391.5 ± 20.6 | 20 | 329.3 ± 15.9 | 370.8 ± 18.3 |
Body weights were measured at the beginning of exposure and at the termination of exposure. Rats were exposed to 14-days RA or 14-days CIH with or without daily treatment with MnTMPyP (Mn treatment), apocynin (Apo treatment) or their vehicle (Veh treatment). Data in each group are the means ± SE. N, animal numbers. There was no significant difference (P > 0.05) in mean body weight between the 14-days RA rats and the 14-days CIH rats with or without daily drug treatments either at the beginning of exposure or at the termination of exposure.